N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Open Access
- 1 March 1994
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (11), 8362-8365
- https://doi.org/10.1016/s0021-9258(17)37202-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Modulation of cell‐surface transferrin receptor by the imino sugar N‐butyldeoxynojirimycinEuropean Journal of Biochemistry, 1992
- Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase geneNature, 1992
- A ceramide analog inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesisBiochemistry, 1990
- Role of glycolipids in the metastatic process: Characteristics of neutral glycolipids in clones with different metastatic potentials isolated from a murine fibrosarcoma cell lineInternational Journal of Cancer, 1990
- ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIAAnnual Review of Biochemistry, 1989
- Inhibition of HIV replication by amino‐sugar derivativesFEBS Letters, 1988
- Antitumor activity via inhibition of glycosphingolipid biosynthesisCancer Letters, 1987
- INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINSAnnual Review of Biochemistry, 1987
- UDPglucose-ceramide glucosyltransferase from porcine submaxillary glands is associated with the Golgi apparatusBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Gangliosides as membrane receptors for tetanus toxin, cholera toxin and serotoninNature, 1974